<PAGE>
Washington, D.C. 20549
FORM 12b-25
Notification of Late Filing
033-1402 NY
----------------
SEC FILE NUMBER
87-0446395
----------------
----------------
CUSIP NUMBER
64124R 10 7
----------------
(Check One):
/ /Form 10-KSB / /Form 11-K / /Form 20-F / /Form 10-QSB / /Form N-SAR
For Period Ended: June 30, 1998
--------------------------------------------
Nothing in this Form shall be construed to imply that the Commission has
verified any information herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- -------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant NEUROCORP, LTD.
(Former Name if Applicable)
- -------------------------------------------------------------------------------
Address of Principal Executive Office 150 WHITE PLAINS ROAD
(Street and Number)
- -------------------------------------------------------------------------------
City, State and Zip Code TARRYTOWN, NEW YORK 10591
PART II -- RULES 12b-25(b) AND (c)
If the subject report could not be filed without reasonable effort or
expense and the Registrant seeks relief pursuant to Rule 12(b-25(b), the
following should be completed. (Check box if appropriate)
/X/ (a) The reasons described in reasonable detail in Part II of this
form could not be eliminated without unreasonable effort or
expense;
/X/ (b) The subject quarterly annual report on Form 10-QSB will be filed
on or before the fifth calendar day following the prescribed due
date.
/ / (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>
PART III -- NARRATIVE
State below in reasonable detail the reason why Form 10-QSB, could not be filed
within the prescribed time period.
Registrant was involved in the finalization of an equity financing
which delayed the completion of its Form W-QSB
The inability to file timely could not be liminated by the
Registrant without unreasonable effort and expense in that until such
change has been completed, it cannot finalize its financial statements.
PART IV -- OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Kurt Z. Itil (914) 631-3315
--------------------- --------------------------
(Name) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If
answer is no, identify report(s).
/X/ Yes / / No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or
portion thereof? If so: attach an explanation of the anticipated change,
both naratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
/X/ Yes / / No
It is anticipated that the Registrant will report a loss from operations
of approximately $1,638,000 for the six months ended June 30, 1998 as
compared to a net loss of $659,000 for the corresponding period in 1997.
The increased loss is attributable to the Registrants' need for working
capital and the completion of an equity financing for such purpose later
than anticipated.
<PAGE>
NEUROCORP, LTD
---------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Dated: August 14, 1998 By: Kurt Z. Itil
--------------------------------------- ----------------------------
Executive Vice President
